Melissa Dean, MD, FAARFM, a highly experienced internal medicine specialist with advanced training in metabolic and nutritional medicine, our team is dedicated to helping you achieve optimal health
Inform your dentist if you have started taking any new medications, like GLP-1 receptor agonists, and if you have any new symptoms such as those listed above
33 Exenatide, also a GLP-1 receptor agonist, in a NASH mouse model showed an improvement of mitochondrial tricarboxylic acid cycle flux after a 8-week treatment, a significant decrease in insulin resistance, steatosis, hepatocyte lipotoxicity and hepatic triglyceride content as well as lower expression of hepatic lipogenic genes (Srebp1C, Cd36) and genes involved in inflammation and fibrosis
Alyssas professional achievements have been recognized nationally and by her peers